| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 21/12/2009 | 12:01 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:AVGN | Avigen (MM) |
| 21/12/2009 | 12:01 | Edgar (US Regulatory) | Termination of Registration of a Class of Security under Section 12(g) (15-12G) | NASDAQ:AVGN | Avigen (MM) |
| 17/12/2009 | 00:29 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVGN | Avigen (MM) |
| 16/12/2009 | 21:12 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVGN | Avigen (MM) |
| 15/12/2009 | 19:38 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AVGN | Avigen (MM) |
| 09/11/2009 | 22:28 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AVGN | Avigen (MM) |
| 23/10/2009 | 23:23 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:AVGN | Avigen (MM) |
| 06/10/2009 | 12:02 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:AVGN | Avigen (MM) |
| 24/09/2009 | 20:05 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:AVGN | Avigen (MM) |
| 16/09/2009 | 00:24 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AVGN | Avigen (MM) |
| 24/08/2009 | 12:22 | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:AVGN | Avigen (MM) |
| 27/05/2009 | 16:03 | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AVGN | Avigen (MM) |
| 30/04/2009 | 12:05 | Edgar (US Regulatory) | Amended Annual Report (10-K/A) | NASDAQ:AVGN | Avigen (MM) |
| 27/03/2009 | 21:18 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:AVGN | Avigen (MM) |
| 27/03/2009 | 18:10 | PR Newswire (US) | Biotechnology Value Fund, L.P. Announces Overwhelming Support to Remove the Board of Directors of Avigen, Inc. at Special Meetin | NASDAQ:AVGN | Avigen (MM) |
| 26/03/2009 | 17:29 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:AVGN | Avigen (MM) |
| 26/03/2009 | 15:59 | Dow Jones News | Avigen Threatens Liquidation If Suitor's Board Candidates Fail | NASDAQ:AVGN | Avigen Inc. |
| 23/03/2009 | 21:37 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AVGN | Avigen (MM) |
| 23/03/2009 | 13:00 | PR Newswire (US) | Leading Advisory Firm, PROXY Governance, Recommends Avigen Shareholders Vote on GOLD Card to Remove Incumbent Directors and Elec | NASDAQ:AVGN | Avigen (MM) |
| 20/03/2009 | 13:45 | PR Newswire (US) | Empirical Search Strategies Seeks Downside Protection Option at Avigen, Inc. | NASDAQ:AVGN | Avigen (MM) |
| 20/03/2009 | 13:00 | PR Newswire (US) | BVF Acquisition LLC Increases Tender Offer Price for Avigen, Inc. to $1.20 Per Share | NASDAQ:AVGN | Avigen (MM) |
| 16/03/2009 | 22:11 | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:AVGN | Avigen (MM) |
| 12/03/2009 | 21:50 | PR Newswire (US) | Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maxi | NASDAQ:AVGN | Avigen (MM) |
| 10/03/2009 | 22:55 | Edgar (US Regulatory) | Proxy Statment - Contested Solicitations (definitive) (DEFC14A) | NASDAQ:AVGN | Avigen (MM) |
| 07/03/2009 | 00:59 | PR Newswire (US) | BVF Acquisition LLC Extends Avigen Tender Offer to April 3, 2009 | NASDAQ:AVGN | Avigen (MM) |
| 04/03/2009 | 12:04 | Edgar (US Regulatory) | Proxy Soliciting Materials (revised) (PRER14A) | NASDAQ:AVGN | Avigen (MM) |
| 21/02/2009 | 01:05 | PR Newswire (US) | BVF Acquisition LLC Extends Avigen Tender Offer to March 6, 2009 | NASDAQ:AVGN | Avigen (MM) |
| 20/02/2009 | 22:40 | Edgar (US Regulatory) | Proxy Statement - Contested Solicitations (preliminary) (PREC14A) | NASDAQ:AVGN | Avigen (MM) |
| 17/02/2009 | 23:30 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | NASDAQ:AVGN | Avigen (MM) |
| 10/02/2009 | 19:04 | PR Newswire (US) | Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders | NASDAQ:AVGN | Avigen (MM) |